The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial.
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Guardant Health; Inivata; Inivata; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Relay therapeutics; Repare Therapeutics; Roche; Zentalis
Research Funding - AstraZeneca (Inst); Guardant Health (Inst); Inivata (Inst); InVitae (Inst); Merck Sharpe and Dohme (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst); Roche (Inst)
 
Frederik Marmé
No Relationships to Disclose
 
Sung-Bae Kim
Stock and Other Ownership Interests - Genopeaks; Neogene Therapeutics; TC Corp
Honoraria - DAEHWA Pharmaceutical; Kalbe Farma; LegoChem Biosciences
Consulting or Advisory Role - AstraZeneca; BeiGene; DAEHWA Pharmaceutical; Daiichi Sankyo/Astra Zeneca; ISU Abxis; Lilly (Inst); OBI Pharma
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Herve R. Bonnefoi
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Pfizer
 
José A. García-Sáenz
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Seagen
Speakers' Bureau - Novartis
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Antonio A. Torres
No Relationships to Disclose
 
Harry Douglas Bear
Stock and Other Ownership Interests - Abbvie; Pfizer; Viatris
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Hans Tesch
Leadership - Care on Coach; CHOP GmbH; Vision med GmbH
Honoraria - AstraZeneca; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Exact Sciences; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Roche
Expert Testimony - AstraZeneca; Daiichi Sankyo Pharmaceutical; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Roche; Seagen
 
Mireia Melé Olivé
No Relationships to Disclose
 
Nicole Mc Carthy
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Pfizer
 
Josefina Cruz Jurado
Consulting or Advisory Role - AstraZeneca; Bayer; DAICHII; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; DAICHII; Gilead Sciences; Novartis; PharmaMar
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Zhe Zhang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Karsten Ernst Weber
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); Daiichi Sankyo Pharmaceutical (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - EP14153692.0 (Inst); EP15702464.7 (Inst); EP19808852.8 (Inst); EP21152186.9 (Inst); VM Scope GmbH (Inst)
Other Relationship - Daiichi Sankyo Pharmaceutical (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
 
Bärbel Felder
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); Daiichi Sankyo Pharmaceutical (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - EP14153692.0 (Inst); EP15702464.7 (Inst); EP19808852.8 (Inst); EP21152186.9 (Inst); VM Scope GmbH (Inst)
Other Relationship - Daiichi Sankyo Pharmaceutical (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
 
Valentina Nekljudova
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi-Sankyo (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - EP14153692.0 (Inst); EP15702464.7 (Inst); EP19808852.8 (Inst); EP21152186.9 (Inst); VM Scope GmbH (Inst)
Other Relationship - Daiichi-Sankyo (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
 
Toralf Reimer
Honoraria - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Carsten Denkert
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Molecular Health; MSD Oncology; Roche
Research Funding - German Breast Group (Inst); Myriad Genetics (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent WO2010076322A1; Patent WO2015114146A1; Patent WO2020109570A1; VMScope digital pathology software
 
Sibylle Loibl
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EirGenix (Inst); Eisai Europe (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Pierre Fabre (Inst); Relay Therapeutics (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst)
Speakers' Bureau - AstraZeneca (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); MolecularHealth (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Digital Ki67 Evaluator, VM Scope GmbH (Inst); Patent Issued EP15702464.7 (Inst); Patent Pending EP14153692.0 (Inst); Patent Pending EP19808852.8 (Inst); Patent Pending EP21152186.9 (Inst)